- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07580755
Mesenchymal Stem Cells in the Treatment of Burn Wounds
5. maj 2026 opdateret af: The First Affiliated Hospital of Xinxiang Medical College
A Randomized Controlled Study on the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Extensive Burns
Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.
Studieoversigt
Status
Rekruttering
Betingelser
Detaljeret beskrivelse
This study adopted a randomized, double-blind, parallel-controlled research method.
It planned to enroll 90 burn patients who underwent autologous thick skin transplantation.
These patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), with 30 patients in each group.
The three groups of subjects received the same treatment under the same conditions simultaneously.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
90
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Wenjie Ren
- Telefonnummer: 13937354075
- E-mail: 13937354075@163.com
Studiesteder
-
-
Henan
-
Xinxiang, Henan, Kina, 453000
- Rekruttering
- The First Affiliated Hospital of Xinxiang Medical College
-
Kontakt:
- Wenjie Ren
- Telefonnummer: 13937354075
- E-mail: 13937354075@163.com
-
Kontakt:
- Wenjie Ren
- E-mail: 13937354075@163.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Voluntary participation and signing of the informed consent form;
- Burn patients, subjects requiring autologous skin grafting;
- Age 18 to 65 years old, gender not restricted;
- During this clinical study, single person, single donor skin area (lateral thigh or trunk) treatment;
- Skin burn area < 30% of total body surface area (TBSA);
- The donor skin area is the first time for donation, and the donor skin area is medium-thick skin (thickness approximately 0.4mm);
- The area of the excised skin flap ≥ 90 cm2;
- Able to cooperate with this study protocol and accept regular postoperative follow-up visits.
Exclusion Criteria:
- Those allergic to sodium alginate (gel component);
- Electric shock injuries, chemical burns, radiation injuries or combined with other traumas;
- Subjects with severe systemic diseases (judged by the researchers);
- Subjects with uncontrolled hypertension or diabetes (judged by the researchers);
- Pregnant or lactating women;
- Subjects whose condition may affect the study assessment or require the concurrent use of medical treatments that may affect the efficacy assessment;
- Subjects with acute or chronic kidney diseases, renal failure or serum creatinine level = 1.5 times the upper limit of normal value;
- Subjects with acute or chronic liver diseases, total bilirubin, alanine aminotransferase, aspartate aminotransferase = 2.0 times the upper limit of normal value;
- Subjects with a history of malignant tumors;
- Subjects who have participated in other clinical studies for less than 3 months;
- Subjects with mental disorders and without self-awareness, unable to express clearly;
- Subjects using immunosuppressants and those who have been using corticosteroids for a long time (more than 1 month) (excluding local application);
- Subjects with infectious diseases (any one of the four items positive in the test);
- Subjects with other severe systemic diseases;
- Other subjects that the researchers consider not eligible for inclusion.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: low-dose stem cell gel group
The gel was applied as the inner dressing evenly to the wound surface.
To ensure a uniform and thick application, the dosage of the gel used in each group was kept consistent.
A medical surgical film was used as the outer dressing, and a layer of gauze was wrapped on the outermost layer.
The gel dressing was used on the day of the surgery, the 3rd day after the surgery, and the 7th day after the surgery.
During each dressing change, the dressing was opened layer by layer and carefully removed, and the residual stem cell gel was washed off with sterile normal saline.
|
Using hydrogels containing low-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting
|
|
Eksperimentel: high-dose stem cell gel group
|
Using hydrogels containing or without differenthigh-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting
|
|
Placebo komparator: with only the gel
|
Using only hydrogels as wound dressings to promote wound healing in burn patients after thick skin grafting
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Re-epiteliseringsområder
Tidsramme: Op til 6 måneder
|
Re-epitelialisering vil blive bestemt ved kliniske evalueringer og optaget med digitale farvefotografier
|
Op til 6 måneder
|
|
Fuldstændig heling af brandsår
Tidsramme: Op til 12 måneder
|
Tid (dage) til at fuldføre re-epitelisering af brændt hud.
Det vil være baseret på kliniske evalueringer og digitale farvefotografier
|
Op til 12 måneder
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
27. april 2026
Primær færdiggørelse (Anslået)
31. december 2027
Studieafslutning (Anslået)
31. december 2028
Datoer for studieregistrering
Først indsendt
28. april 2026
Først indsendt, der opfyldte QC-kriterier
5. maj 2026
Først opslået (Faktiske)
12. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
5. maj 2026
Sidst verificeret
1. oktober 2025
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MSCBW-2022
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Forbrændingsskade
-
King Edward Medical UniversityTilmelding efter invitationPost Burn HyperpigmentationPakistan
-
Cairo UniversityAfsluttetForbrændinger | Hypertrofisk ar | Burn Scar (Post-Burn)Egypten
-
Cairo UniversityIkke rekrutterer endnuBurn i underekstremiteten | Funktion i underekstremitetenEgypten
-
Cairo UniversityRekruttering
-
VA Office of Research and DevelopmentIkke rekrutterer endnu
-
Central Arkansas Veterans Healthcare SystemUnited States Department of Defense; University of ArkansasRekrutteringÅbn Burn Pit ExposureForenede Stater
-
Truway Health, Inc.Tilmelding efter invitationEvaluering af In-Vitro Cryo Terapeutiske Protokoller på Humane Celleprøver (TWH-CRYO-001) (CRYO-IVT)Cellular Injury and Post-Cryogenic Recovery | Kryogenisk cellulær stress | Kuldeinduceret cellulær skade | Termisk Skade Reaktion | Post-thaw levedygtighedsforringelse | Osmotisk Stressskade | Biomekanisk Skadesmodellering (In-Vitro) | Blunt Force Injuries to the Extremities (Cellular Injury Model) | Vævsskade... og andre forholdForenede Stater
-
Nepal Health Research CouncilFogarty International Center of the National Institute of HealthRekruttering
-
Cairo UniversityAfsluttet
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and...AfsluttetModerat til alvorligt traume, som defineret af en | Injury Severity Score (ISS) > 12 point var inkluderet i undersøgelsen.Spanien